Funds in Health

Real  hope for two children (My Daughter) Fund
→
1 nonprofit
Real hope for two children (My Daughter) Fund
❤️ A PERSONAL APPEAL TO MY ASML COLLEAGUES Dear colleagues, At ASML, we work every day on complex challenges and push the boundaries of what technology can achieve. But the greatest challenge in my life has nothing to do with lithography. My daughter Isis and another Dutch child, Seppe, have a rare and highly progressive heart disease called restrictive cardiomyopathy, caused by variants in the TNNI3 gene. Their heart muscles cannot relax properly, making it difficult for their hearts to fill with blood. Both children already have significantly elevated pressures in their hearts. There is currently no treatment that addresses the underlying disease. Within three years after diagnosis, around half of affected children have died or required a heart transplant. We are now 2.7 years beyond Isis’s diagnosis. For us, time matters. 🔬 A REAL SCIENTIFIC OPPORTUNITY A promising peptide called C27, discovered by Professor Jian-Ping Jin at the University of Illinois Chicago, is designed to restore the heart’s ability to relax. Published laboratory research supports its mechanism, although C27 has not yet been tested in patients. With money raised by Stichting Tikkertje and matching support from the Dutch Heart Foundation, researchers at UMC Utrecht created patient-specific heart models from Isis and Seppe. These models offer a unique opportunity to test C27 in heart tissue carrying the children’s own genetic variants. ✅ WHAT WE HAVE ACHIEVED • Published scientific evidence supporting the C27 mechanism • Patient-specific stem-cell models from Isis and Seppe • Support from experienced academic and clinical partners • A concrete research and development plan • A Foresight research proposal ready for funding 🚀 FROM SCIENCE TOWARDS PATIENTS I founded Lusitro B.V. to bring together the science, research partners and development expertise needed to move C27 towards patients. I also wrote and developed the Foresight research proposal together with leading academic partners. The proposed programme aims to: • Test whether C27 improves relaxation in the heart models of Isis and Seppe • Develop a PET tracer to determine whether C27 reaches the human heart • Prepare the manufacturing, safety and regulatory evidence needed for clinical development • Prepare an exploratory Phase 0 first-in-human microdosing study in parallel The Phase 0 study would use a very small, non-therapeutic dose. It would not test whether C27 works as a treatment, but whether it reaches the heart and how it behaves in the human body. Preparing this route in parallel could save valuable time. 💶 WHY YOUR SUPPORT IS NEEDED NOW The Foresight proposal is ready for funding, but Lusitro must provide its own substantial cash contribution to unlock the wider research programme. I am personally investing in this work, but I cannot fund the required contribution alone. Your donation through Bright Funds will support the programme via Stichting Tikkertje and help us take the following critical steps: • Patient-specific testing of C27 • Peptide and PET-tracer development • Biodistribution and safety research • Preparation for first-in-human microdosing • Regulatory and clinical-development work ❄️ A POSSIBLE SNOWBALL EFFECT If successful, this programme could generate the evidence and momentum needed to attract further research partners and funding. It could accelerate C27 towards patients and potentially open new possibilities for treating other cardiomyopathies in which impaired heart relaxation plays a role. The immediate priority, however, remains Isis and Seppe. 🙏 I AM ASKING FOR YOUR HELP We cannot promise that C27 will become a treatment. But we now have: • A scientifically grounded therapeutic candidate • Heart models made from the children’s own cells • Experienced research partners • A concrete development programme • A realistic opportunity to find out whether C27 can help I want to be able to tell my daughter that we did everything possible to give her a chance, and that we did not allow a lack of funding to stop us from finding out. ❤️ FOR ISIS. FOR SEPPE. FOR THEIR FUTURE. Every contribution, large or small, helps us take the next critical step. Thank you for reading our story and for any support you can give. Mark Hage Your colleague at ASML Founder of Lusitro | Father of Isis 👉 Please donate through this Bright Funds campaign. 🔗 More about the research: https://www.lusitro.com 🔗 About the foundation: https://www.stichtingtikkertje.nl
Vrienden van Sophia Fund
→
0 nonprofits
Vrienden van Sophia Fund
Erasmus MC Sophia Children's Hospital The Erasmus MC Sophia Children’s Hospital provides care for children with rare and complex disorders. The Sophia is part of the Erasmus Medical Centre and is affiliated with the Erasmus University Rotterdam. The hospital is the largest of the eight university medical centres in the Netherlands. The Erasmus MC Sophia Children’s Hospital is founded more than 150 years ago, we offer the entire spectrum of specialisms in the field of pediatric medicine, surgery, and psychiatry. The knowledge of all the disciplines involved in Sophia Children’s Hospital is bundled into four focus areas: The Pediatric Thoracic Centre, The Pediatric Brain Centre, The Centre for Rare Diseases and The Mother and Child Centre. Erasmus MC Sophia Foundation Children should not be sick, but unfortunately reality tells a different story. That is why the Erasmus MC Sophia Foundation is committed to funding scientific research to discover the causes of diseases and to improve treatment methods. The Foundation contributes to projects to enable innovations in healthcare, so that the Sophia retains a leading position as a children’s hospital in Europe. At the Sophia, it is all about the patients. High quality and safety of care is paramount. The government and health insurers make an important contribution to the financing of medical treatments. However, additional resources are needed for optimal well-being of patients, research and new treatment methods, education, and relaxation. The Erasmus MC Sophia Foundation (in Dutch: Stichting Vrienden van het Sophia) is a fundraising foundation that raises money for the facilities mentioned above. Thanks to the many donations, the Erasmus MC Sophia Foundation can create facilities that fall outside the regular healthcare coverage. Such as projects that can take healthcare to an even higher level. And projects that make the stay of patients and their families in hospital as pleasant as possible. Such as furnishing family rooms, toys, and relaxation options. These facilities are of crucial importance for the well-being of the child and family during the sometimes-long periods of hospitalisation at the Sophia and during the recovery period afterwards. The support of donors, companies, funds and volunteers is indispensable. Together we can make a big difference in the lives of little ones! We are very grateful to our donors for their support.
In Honor of Frits Klostermann, lithography pioneer - Support the MPN Foundation Fund
→
1 nonprofit
In Honor of Frits Klostermann, lithography pioneer - Support the MPN Foundation Fund
At ASML, we stand on the shoulders of giants. One of those giants was Frits Klostermann (1933–2024), a true pioneer in precision systems for lithography and one of the driving forces behind ASML in its earliest days. His legacy of innovation and dedication continues to inspire us. He is hardly known in ASML circles, but Frits Klostermann helped lay the foundation for the lithography from which the company emerged at the Philips Physics Laboratory (Natlab). Not only from a technological point of view, he involved many researchers and employees of the workshop in the development of a mask writer and photo repeater for chip contact masks. In memory of Frits and in support of a cause close to many, we invite you to consider donating to the MPN Foundation. The MPN Foundation is committed to improving the lives of patients with myeloproliferative neoplasms (MPNs)—a group of rare blood cancers that includes essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). These diseases are characterized by the overproduction of blood cells in the bone marrow, and they can be difficult to diagnose and treat due to their rarity. Founded in 2003, the MPN Foundation serves as a vital resource for patients, their families, and healthcare professionals. It promotes: Scientific research through its dedicated Research Foundation (FWO), which is funded entirely by donations, legacies, and overpayments from donors. Awareness and education among physicians to improve diagnosis and treatment. Community support, offering patients a place to connect and share experiences. Every contribution to the MPN Foundation’s FWO goes directly to supporting research and patient care—100% of your donation makes a difference. Let’s honor Frits Klostermann’s legacy not only by remembering his contributions to technology but also by supporting a cause that brings hope and progress to those facing MPNs. Learn more and donate at: https://www.mpn-stichting.nl Together, we can make a meaningful impact.
For a future free from Dialysis Fund
→
1 nonprofit
For a future free from Dialysis Fund
Dialysis is degenerative. People go on dialysis and decay, psychologically and physically, until they are socially isolated. Then, they die in silence. There is no awareness, and so no desire to change this. Despite heavy cost to both the patient and the state (~5% of all health care spending) This is the reason dialysis has remained the same for 50 years. As someone who was on dialysis and now working to end it, Tuğrul Irmak and the team at Nephrology want to make a difference. They want to build a bio-artificial kidney. For this we need to raise not only funds but awareness, for it is the lack of awareness that has blocked progress. About Tuğrul Irmak He is extremely motivated to end the threat of dialysis that hangs like a dark cloud over every kidney patient. As a mountain climber and kidney patient himself, Tuğrul Irmak takes action for a future free of kidney dialysis. His target is €1 million. But he goes much further than just a fundraiser: as a researcher at the UMC Utrecht, Tuğrul himself is also working on an artificial implantable kidney. He just started a campaign: the Climb Against Time . Tuğrul: “The transplant gave me my life back — or at least let it continue. But my kidney has a limited lifespan. I spoke to people in the same situation whose transplant failed and who had to go back to dialysis. With this campaign, we want to raise money for Artificial Kidney Research. Dialysis patients have to make a constant, tough climb to survive. To symbolize this, we are going to climb!” Tuğrul invites people to donate, but also to participate in the Climb and take on their own challenge. “Walk, cycle, run or climb. Use your summer vacation for a good cause.” Via Friends of UMC Utrecht & Wilhelmina Children's Hospital, the donations will end up in the right place.